Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fRPE Cell Transplantation in Dry AMD
NCT02868424Phase 1Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Feb 2016
- Primary completion
- Aug 2018
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fetal retinal pigment epithelium in age-related macular degeneration (AMD), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Number of subjects with adverse events at 2 years. Status: unknown.
02
Drugs
fetal retinal pigment epithelium
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT02868424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868424.